{"id":332768,"date":"2026-10-29T17:22:57","date_gmt":"2026-10-29T11:52:57","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/bliss-gvs-pharma-q2-results-fy27-pat-53-crore\/"},"modified":"2026-10-29T17:22:57","modified_gmt":"2026-10-29T11:52:57","slug":"bliss-gvs-pharma-q2-results-fy27-pat-53-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/bliss-gvs-pharma-q2-results-fy27-pat-53-crore\/","title":{"rendered":"Bliss GVS Pharma Q2 Results FY27: PAT Jumps 86.57% to Rs 53.34 Cr, Revenue Rs 313.37 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Bliss GVS Pharma Q2 Results FY27 were declared on 29 October 2026 on a Consolidated basis. Revenue rose 28.22% to Rs 313.37 Cr from Rs 244.40 Cr a year earlier, while net profit grew 86.57% to Rs 53.34 Cr from Rs 28.59 Cr. These quarterly results also show Operating Profit up 85.33% to Rs 80.58 Cr, so YoY growth is strong across all three lines.<\/p>\n<\/div>\n

Bliss GVS Pharma Ltd<\/a> (BLISSGVS) Q2 Results FY27 announced on 29 October 2026, covering the company’s financial performance for the July to September quarter. The results date brought consolidated results with revenue of Rs 313.37 Cr and PAT of Rs 53.34 Cr, and Bliss GVS Pharma Q2 Results FY27 show revenue 28.22% higher than the same quarter last year on a Consolidated basis.<\/p>\n

Bliss GVS Pharma Q2 Results are examined here through a results analysis that covers the financial highlights, business drivers, outlook and risks. The figures below set out how revenue, Operating Profit and net profit moved against the same quarter last year, starting with the Financial Highlights table.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n